RetaMaps

BitCure Mindful Health

BitCure Mindful Health · 4750 Ashwood Drive · Blue Ash, OH 45241

5.0· 9 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 9 reviews
5
reviews in the past year (avg ★ 5.0)
1
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-08-10. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 9 Google reviews. Of the 6 reviews we analyzed, 6 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

What patients like

  • Knowledgeable, professional providers2 reviews
  • Feeling listened to2 reviews

Common complaints

No negative reviews among those we analyzed.

5★
6
4★
0
3★
0
2★
0
1★
0

Most recent Google reviews

Ken K.★★★★★2026-08-10

This was a definitely huge help for me. Getting blood drawn and then having everything explained very well to me. Having accountability coaches and being able to walk you through what the best way is for you to help yourself and have somebody coach you through it was wonderful. I highly recommend it if you want to get yourself healthy, lose weight and stay off of Medicine take a look at their program. P

Barb M.★★★★★2026-07-27

This is the place to go if you truly want to learn how to improve your health and wellbeing. You will be supported every step of the way in your journey. BitCure gives you the tools you need to change your life, not a quick fix that is temporary. The team truly cares about your success.

Clark D.★★★★★2026-07-13

The staff is always friendly, welcoming, and professional from the moment you walk in. They truly take the time to listen to your medical concerns and never make you feel rushed. It's clear they genuinely care about their patients and want to provide the best possible care. Finding a healthcare provider that makes you feel heard and valued isn't always easy, and BitCure does exactly that. I highly recommend them to anyone looking for compassionate, patient-focused care.

Lindsey N.★★★★★2024-01-03

I have never felt more respected and listened to as a patient of any practice. before going to Ashley. She is thorough and attentive to details and truly focuses on each patient as a person. Laura is wonderful as well. Cannot recommend Bitcure enough!

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Blue Ash

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs